VIRGINIA RETIREMENT SYSTEMS ET AL - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 178 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,072,656
+210.6%
248,300
+373.9%
0.01%
+266.7%
Q2 2023$345,316
+0.7%
52,400
+3.8%
0.00%
-25.0%
Q1 2023$342,895
+19.9%
50,500
+30.5%
0.00%
+33.3%
Q4 2022$285,993
-18.5%
38,700
+9.0%
0.00%
-25.0%
Q3 2022$350,740
+38.6%
35,500
+58.5%
0.00%
+100.0%
Q1 2022$253,000
-42.6%
22,400
-20.3%
0.00%
-33.3%
Q4 2021$441,000
-31.9%
28,100
-25.7%
0.00%
-57.1%
Q3 2021$648,000
-38.8%
37,800
-23.2%
0.01%
-30.0%
Q2 2021$1,058,000
+40.9%
49,200
-1.6%
0.01%
+42.9%
Q1 2021$751,000
+5.6%
50,000
-7.6%
0.01%0.0%
Q4 2020$711,000
+173.5%
54,100
+101.1%
0.01%
+133.3%
Q3 2020$260,000
-84.9%
26,900
-59.2%
0.00%
-87.0%
Q4 2018$1,725,000
+98.3%
66,000
+74.1%
0.02%
+130.0%
Q3 2018$870,000
+15.4%
37,900
-4.3%
0.01%
+11.1%
Q2 2018$754,000
+312.0%
39,600
+253.6%
0.01%
+350.0%
Q2 2017$183,000
-5.2%
11,200
-18.8%
0.00%0.0%
Q1 2017$193,000
-46.5%
13,800
-36.4%
0.00%
-60.0%
Q3 2016$361,000
+61.2%
21,700
-10.0%
0.01%
+66.7%
Q1 2015$224,00024,1000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,532,000$27,423,0003.23%
Stonepine Capital Management, LLC 300,000$5,370,0003.16%
Palo Alto Investors LP 4,155,670$74,386,0003.13%
GREAT POINT PARTNERS LLC 497,531$8,906,0001.73%
Avoro Capital Advisors LLC 988,270$17,690,0001.37%
UNIVERSITY OF NOTRE DAME DU LAC 157,781$2,824,0000.79%
Birchview Capital, LP 68,000$1,217,0000.63%
Cheyne Capital Management (UK) LLP 74,000$1,323,0000.48%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 352,604$6,311,0000.43%
361 CAPITAL LLC 119,554$2,140,0000.41%
View complete list of VANDA PHARMACEUTICALS INC shareholders